{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:06:27Z","timestamp":1781766387897,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jns.2008.04.016","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T17:05:23Z","timestamp":1211994323000},"page":"131-136","source":"Crossref","is-referenced-by-count":16,"title":["The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide"],"prefix":"10.1016","volume":"271","author":[{"given":"Amjad","family":"Abuirmeileh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harkavyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Kingsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.04.016_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","article-title":"Cell death in development","volume":"96","author":"Vaux","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jns.2008.04.016_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2008.04.016_bib3","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson's disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2008.04.016_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a potential causative factor in the aetiology of Parkinsons disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jns.2008.04.016_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1523\/JNEUROSCI.22-02-00404.2002","article-title":"Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type 1","volume":"22","author":"Pederson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2008.04.016_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0028-3908(03)00211-9","article-title":"Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors","volume":"45","author":"Facci","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2008.04.016_bib7","article-title":"Urocortin attenuates key indicators of nigrostriatal pathway destruction in a rat hemiparkinsonian model","author":"Biggs","year":"2006","journal-title":"Proc Br Pharm Soc"},{"key":"10.1016\/j.jns.2008.04.016_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1460-9568.2007.05653.x","article-title":"The corticotrophin releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease","volume":"26","author":"Abuirmeileh","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jns.2008.04.016_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-4-19","article-title":"Urocortin, a CRF-like peptide, restores key indicators of damage in a neuroinflammatory model of Parkinson's disease","volume":"4","author":"Abuirmeileh","year":"2007","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jns.2008.04.016_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00702-004-0121-3","article-title":"Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons","volume":"112","author":"Herrera","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2008.04.016_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2008.04.016_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3727\/000000007783464632","article-title":"Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application","volume":"16","author":"Yasuhara","year":"2007","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jns.2008.04.016_bib13","first-page":"51","article-title":"Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease","volume":"61","author":"Yasuhara","year":"2006","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jns.2008.04.016_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7","article-title":"Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion","volume":"427","author":"Zuch","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jns.2008.04.016_bib15","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1471-4159.1992.tb11001.x","article-title":"Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in the rat brain: an in vivo microdialysis study","volume":"59","author":"Biggs","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2008.04.016_bib16","article-title":"Urocortin restores striatal extracellular DA in the 6-hydroxydopamine hemiparkinsonian rat","author":"Abuirmeileh","year":"2007","journal-title":"Proc Phys Soc"},{"key":"10.1016\/j.jns.2008.04.016_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2008.04.016_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl041","article-title":"New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis","volume":"129","author":"Tande","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.04.016_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1677\/joe.0.1720283","article-title":"Urocortin increases the expression of heat shock protein 90 in rat cardiac myocytes in a MEK1\/2-dependent manner","volume":"172","author":"Brar","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jns.2008.04.016_bib20","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1074\/jbc.275.12.8508","article-title":"Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway","volume":"275","author":"Brar","year":"2000","journal-title":"J Biol Chem"},{"issue":"Suppl. B","key":"10.1016\/j.jns.2008.04.016_bib21","first-page":"107","article-title":"A CRF family peptide protects a human chondrocyte cell line against apoptosis","volume":"12","author":"Intekhad-Alam","year":"2004","journal-title":"Osteoarthr Cartilage"},{"key":"10.1016\/j.jns.2008.04.016_bib22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/gut.2005.084525","article-title":"Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease","volume":"55","author":"Gonzalez-Rey","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jns.2008.04.016_bib23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1460-9568.2004.03279.x","article-title":"Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro","volume":"19","author":"Swinny","year":"2004","journal-title":"Eur J Neurosci"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08001640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T18:06:49Z","timestamp":1557598009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08001640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0022510X08001640"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.04.016","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}